{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:30:19Z","timestamp":1794839419756,"version":"4.9.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Platelet count is considered as a biomarker for the development of coronary artery abnormalities (CAAs) among Kawasaki disease (KD) patients. However, previous studies have reported inconsistent results. We addressed the controversial association of platelet count with CAAs using a large-scale dataset.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective cohort study was conducted using KD survey data from Japan (2015\u20132016; n = 25,448). Classifying patients by intravenous immunoglobulin (IVIG) responsiveness, we described the trends in platelet count using the lowest and highest values along with the specific illness days. Multivariate logistic regression analysis was performed to evaluate the association between platelet count and CAAs, adjusting for relevant factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Platelet counts rapidly decreased from admission, reached the lowest count at 6\u20137 days, and peaked after 10 days. Platelet counts in IVIG non-responders decreased with a lower minimum value than IVIG responders, but subsequently rebounded toward a higher maximum. Compared with patients with normal platelet counts (150\u2013450\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L), patients with abnormally high platelet counts (&gt;450\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) were more likely to have CAAs at admission (adjusted odds ratio: IVIG responders, 1.50 [95% confidence interval 1.20\u20131.87] and non-responders, 1.46 [1.01\u20132.12]). By contrast, IVIG non-responding patients whose counts were below normal (&lt;150\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) after hospitalization were at higher risk for developing CAAs (2.27 [1.44\u20133.58]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Platelet count varied widely by illness day and was confounded by IVIG responsiveness, which might have contributed to previous inconsistent findings. KD patients with abnormally high platelet counts at admission or abnormally low counts after hospitalization were at higher risk for CAAs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002563","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T13:45:13Z","timestamp":1576590313000},"page":"197-203","source":"Crossref","is-referenced-by-count":25,"title":["Platelet Count Variation and Risk for Coronary Artery Abnormalities in Kawasaki Disease"],"prefix":"10.1097","volume":"39","author":[{"given":"Ryusuke","family":"Ae","sequence":"first","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Y.","family":"Abrams","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Maddox","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Schonberger","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosikazu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Shindo","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Makino","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kosami","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Sasahara","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias D.","family":"Belay","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1756-185X.13209","article-title":"Role of glucocorticoids in Kawasaki disease.","volume":"21","author":"Miura","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1756-185X.13208","article-title":"Adjunctive therapies in Kawasaki disease.","volume":"21","author":"Tremoulet","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2013.01.022","article-title":"Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.","volume":"163","author":"Kobayashi","year":"2013","journal-title":"J Pediatr"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","article-title":"Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.","volume":"99","author":"Chen","year":"2013","journal-title":"Heart"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2352-4642(18)30293-1","article-title":"Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.","volume":"2","author":"Miyata","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","article-title":"Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.","volume":"166","author":"Sano","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/ijms17030278","article-title":"Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome.","volume":"17","author":"Rigante","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.","volume":"158","author":"Sleeper","year":"2011","journal-title":"J Pediatr"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/archdischild-2014-307397","article-title":"Predicting IVIG resistance in UK Kawasaki disease.","volume":"100","author":"Davies","year":"2015","journal-title":"Arch Dis Child"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00296-016-3499-y","article-title":"Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.","volume":"36","author":"S\u00e1nchez-Manubens","year":"2016","journal-title":"Rheumatol Int"},{"key":"R15-20230912","first-page":"209","article-title":"Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.","volume":"38","author":"Chantasiriwan","year":"2018","journal-title":"Paediatr Int Child Health"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5603\/KP.a2016.0179","article-title":"Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.","volume":"75","author":"Berdej-Szczot","year":"2017","journal-title":"Kardiol Pol"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpeds.2016.07.035","article-title":"The combined usefulness of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease.","volume":"178","author":"Kawamura","year":"2016","journal-title":"J Pediatr"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"e0176957","DOI":"10.1371\/journal.pone.0176957","article-title":"A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (IVIG)-resistance in Kawasaki disease.","volume":"12","author":"Takeshita","year":"2017","journal-title":"PLoS One"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00431-018-3182-2","article-title":"Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.","volume":"177","author":"Li","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R20-20230912","first-page":"857","article-title":"Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease.","volume":"6","author":"Niwa","year":"1995","journal-title":"Coron Artery Dis"},{"key":"R21-20230912","first-page":"e201727","article-title":"Acute Kawasaki disease with emphasis on the echocardiographic profile: a single center experience.","volume":"2017","author":"Hamza","year":"2017","journal-title":"Glob Cardiol Sci Pract"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/tropej\/fmv090","article-title":"The clinical profile of Kawasaki disease in Algerian children: a single institution experience.","volume":"62","author":"Boudiaf","year":"2016","journal-title":"J Trop Pediatr"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2188\/jea.JE20140128","article-title":"Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.","volume":"25","author":"Kuwabara","year":"2015","journal-title":"J Epidemiol"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00296-014-3186-9","article-title":"Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.","volume":"35","author":"Maric","year":"2015","journal-title":"Rheumatol Int"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ped.13544","article-title":"Epidemiological observations of Kawasaki disease in Japan, 2013-2014.","volume":"60","author":"Makino","year":"2018","journal-title":"Pediatr Int"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatr Int"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1253\/circj.CJ-66-0096","article-title":"Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.","volume":"78","year":"2014","journal-title":"Circ J"},{"issue":"5 pt 1","key":"R29-20230912","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(05)81894-3","article-title":"Outcome of coronary artery aneurysms after Kawasaki disease.","volume":"121","author":"Akagi","year":"1992","journal-title":"J Pediatr"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2017.05.034","article-title":"Cardiac complications, earlier treatment, and initial disease severity in Kawasaki disease.","volume":"188","author":"Abrams","year":"2017","journal-title":"J Pediatr"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(84)80114-6","article-title":"Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms.","volume":"105","author":"Burns","year":"1984","journal-title":"J Pediatr"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bmj.290.6480.1456","article-title":"Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.","volume":"290","author":"Levin","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/INF.0b013e31822d4f56","article-title":"Evolution of laboratory values in patients with Kawasaki disease.","volume":"30","author":"Tremoulet","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ped.13809","article-title":"Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.","volume":"61","author":"Makino","year":"2019","journal-title":"Pediatr Int"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1253\/circj.CJ-17-0046","article-title":"On what day of illness does the dilatation of coronary arteries in patients with Kawasaki disease begin?","volume":"82","author":"Fuse","year":"2017","journal-title":"Circ J"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmii.2016.06.004","article-title":"Characteristics of children with Kawasaki disease requiring intensive care: 10 years\u2019 experience at a tertiary pediatric hospital.","volume":"51","author":"Kuo","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jpids\/piw081","article-title":"Hyponatremia is a feature of Kawasaki disease shock syndrome: a Case-Control Study.","volume":"6","author":"Schuster","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/INF.0000000000000891","article-title":"Patterns of fever in children after primary treatment for Kawasaki disease.","volume":"34","author":"Jaggi","year":"2015","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:16:36Z","timestamp":1694556996000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002563","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}